Form 4 for TECH Bio-Techne
Accepted 2026-05-07 17:22:11 ET · period of report 2026-05-05 · accession 0000914190-26-000088 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-07 17:22 | 2026-05-05 | TECH | Kelderman Kim | CEO, Dir | M - OptEx | $47.60 | +26.7K | 89.8K | +42% | +$1.27M |
| D | 2026-05-07 17:22 | 2026-05-05 | TECH | Kelderman Kim | CEO, Dir | F - Tax | $56.68 | -24.0K | 65.8K | -27% | -$1.36M |
| D | 2026-05-07 17:22 | 2026-05-05 | TECH | Kelderman Kim | CEO, Dir | M - OptEx | $0.00 | -26.7K | 35.0K | -43% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-05 | M | A | 26,692 | $47.60 | 89,750 | D | — | — | |
| 2 | Common | Common Stock | 2026-05-05 | F | D | 23,951 | $56.68 | 65,799 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-05-05 | M | D | 26,692 | $0.00 | 35,000 | D | $47.60 · — to 2026-08-07 | 26,692 Common Stock | (F1) Fully exercisable. |